{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:58:46Z","timestamp":1773662326397,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,12]]},"DOI":"10.1007\/bf01836069","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T16:26:00Z","timestamp":1119975960000},"page":"253-259","source":"Crossref","is-referenced-by-count":58,"title":["Pharmacokinetics and hemostatic effect of different factor VIII\/von Willebrand factor concentrates in von Willebrand's disease type III"],"prefix":"10.1007","volume":"65","author":[{"given":"S.","family":"Lethagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01836069_CR1","first-page":"43","volume":"4","author":"LM Aledort","year":"1991","unstructured":"Aledort LM (1991) Von Willebrand's disease \u2014 a therapeutic challenge. Biomedical Progress 4: 43\u201346","journal-title":"Biomedical Progress"},{"key":"BF01836069_CR2","first-page":"23","volume-title":"Platelets in biology and pathology","author":"HR Baumgartner","year":"1976","unstructured":"Baumgartner HR, Muggli R (1976) Adhesion and aggregation: morphologic demonstration, quantitation in vivo and in vitro, chap. 1. In: Gordon JL (ed) Platelets in biology and pathology. North Holland Amsterdam, pp 23\u201366"},{"key":"BF01836069_CR3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(66)92985-0","volume":"2","author":"E Bennett","year":"1966","unstructured":"Bennett E, Dormandy K (1966) Pool's cryoprecipitate and exhausted plasma in the treatment of Willebrand's disease and factor XI deficiency. Lancet 2: 731\u2013732","journal-title":"Lancet"},{"key":"BF01836069_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0609.1988.tb00825.x","volume":"40","author":"E Berntorp","year":"1988","unstructured":"Berntorp E, Nilsson IM (1988) Biochemical and in vivo properties of commercial virus-inactivated factor VIII concentrates. Eur J Haematol 40: 205\u2013214","journal-title":"Eur J Haematol"},{"key":"BF01836069_CR5","first-page":"212","volume":"56","author":"E Berntorp","year":"1989","unstructured":"Berntorp E, Nilsson IM (1989) Use of a high-purity factor VIII concentrate (Hemate-P) in von Willebrand's disease. Vox Sang 56: 212\u2013217","journal-title":"Vox Sang"},{"key":"BF01836069_CR6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003088-199222050-00005","volume":"22","author":"S Bj\u00f6rkman","year":"1992","unstructured":"Bj\u00f6rkman S, Carlsson M, Berntorp E, Stenberg P (1992) Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies. Clin Pharmacokinet 22: 385\u2013295","journal-title":"Clin Pharmacokinet"},{"key":"BF01836069_CR7","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1001\/jama.1976.03270250038023","volume":"236","author":"PM Blatt","year":"1976","unstructured":"Blatt PM, Brinkhous KM, Culp HR, Krauss JS, Roberts HR (1976) Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities. JAMA 236: 2770\u20132772","journal-title":"JAMA"},{"key":"BF01836069_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.1992.tb01159.x","volume":"62","author":"M Burnouf-Radosevich","year":"1992","unstructured":"Burnouf-Radosevich M, Burnouf T (1992) Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate. Vox Sang 62: 1\u201311","journal-title":"Vox Sang"},{"key":"BF01836069_CR9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.1990.tb02655.x","volume":"75","author":"AM Cumming","year":"1990","unstructured":"Cumming AM, Fildes S, Cumming IR, Wensley RT, Redding OM, Burn AM (1990) Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease. Br J Haematol 75: 234\u2013239","journal-title":"Br J Haematol"},{"key":"BF01836069_CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1989.tb00226.x","volume":"73","author":"AB Federici","year":"1989","unstructured":"Federici AB, Bader R, Pagani S, Colibretti ML, De Marco L, Mannucci PM (1989) Binding of von Willebrand factor to glycoproteins Ib and IIb\/IIIa complex: affinity is related to multimeric size. Br J Haematol 73: 93\u201399","journal-title":"Br J Haematol"},{"key":"BF01836069_CR11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2141.1992.tb08903.x","volume":"80","author":"J Goudemand","year":"1992","unstructured":"Goudemand J, Mazurier C, Marey A, et al. (1992) Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low FVIII activity. Br J Haematol 80: 214\u2013221","journal-title":"Br J Haematol"},{"key":"BF01836069_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood.V68.1.58.58","volume":"68","author":"HR Gralnick","year":"1986","unstructured":"Gralnick HR, Rick ME, McKeown LP, et al. (1986) Platelet von Willebrand factor: an important determinant of the bleeding time in type-I von Willebrand's disease. Blood 68: 58\u201361","journal-title":"Blood"},{"key":"BF01836069_CR13","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/S0021-9258(18)68793-9","volume":"263","author":"RJ Kaufman","year":"1988","unstructured":"Kaufman RJ, Wasley LC, Dorner AJ (1988) Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 263: 6352\u20136362","journal-title":"J Biol Chem"},{"key":"BF01836069_CR14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI113721","volume":"82","author":"JA Koedam","year":"1988","unstructured":"Koedam JA, Meijers JCM, Sixma JJ, Bouma BN (1988) Inactivation of human factor VIII by activated protein C: cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82: 1236\u20131243","journal-title":"J Clin Invest"},{"key":"BF01836069_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/00365518509160967","volume":"45","author":"S Lamme","year":"1985","unstructured":"Lamme S, Wallmark A, Holmberg L, Nilsson IM, Sj\u00f6gren H-O (1985) The use of monoclonal antibodies in measuring factor VIII\/von Willebrand factor. Scand J Lab Invest 45: 17\u201326","journal-title":"Scand J Lab Invest"},{"key":"BF01836069_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0609.1992.tb00906.x","volume":"49","author":"S Lethagen","year":"1992","unstructured":"Lethagen S, Nilsson IM (1992) DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand Factor and the platelet receptor GP IIb\/IIIa. Eur J Haematol 49: 7\u201313","journal-title":"Eur J Haematol"},{"key":"BF01836069_CR17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1600-0609.1986.tb02636.x","volume":"37","author":"S Lethagen","year":"1986","unstructured":"Lethagen S, Ostergaard H, Nilsson IM (1986) Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's disease. Scand J Haematol 37: 448\u2013453","journal-title":"Scand J Haematol"},{"key":"BF01836069_CR18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","volume":"1","author":"PM Mannucci","year":"1977","unstructured":"Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A (1977) 1-Deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 1: 869\u2013872","journal-title":"Lancet"},{"key":"BF01836069_CR19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","volume":"66","author":"PM Mannucci","year":"1985","unstructured":"Mannucci PM, Lombardi R, Bader R, et al. (1985) Heterogeneity of type-I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 66: 796\u2013802","journal-title":"Blood"},{"key":"BF01836069_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.2830250106","volume":"25","author":"PM Mannucci","year":"1987","unstructured":"Mannucci PM, Moia M, Rebulla O, Altieri D, Monteagudo J, Castillo (1987) Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor. Am J Hematol 25: 55\u201365","journal-title":"Am J Hematol"},{"key":"BF01836069_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.1991.tb00918.x","volume":"61","author":"C Mazurier","year":"1991","unstructured":"Mazurier C, Jorieux S, de Romeuf C, Samor B, Goudemand M (1991) In vitro evaluation of a very-high-purity, solvent\/detergent-treated, von Willebrand factor concentrate. Vox Sang 61: 1\u20137","journal-title":"Vox Sang"},{"key":"BF01836069_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0609.1984.tb02543.x","volume":"33","author":"IM Nilsson","year":"1984","unstructured":"Nilsson IM (1984) Von Willebrand's disease from 1926\u20131983. Scand J Haematol 33: 21\u201343","journal-title":"Scand J Haematol"},{"key":"BF01836069_CR23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1977.tb01028.x","volume":"37","author":"IM Nilsson","year":"1977","unstructured":"Nilsson IM, Hedner U (1977) Characteristics of various factor VIII concentrates used in treatment of hemophilia A. Br J Haematol 37: 543\u2013557","journal-title":"Br J Haematol"},{"key":"BF01836069_CR24","first-page":"443","volume-title":"Hemophilia and von Willebrand's disease in the 1990s","author":"IM Nilsson","year":"1991","unstructured":"Nilsson IM, Lethagen S (1991) Current status of DDAVP formulations and their use. In: Lusher JM, Kessler CM (eds) Hemophilia and von Willebrand's disease in the 1990s. Elsevier Science Publishers, Amsterdam, pp 443\u2013453"},{"key":"BF01836069_CR25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0954-6820.1957.tb00123.x","volume":"159","author":"IM Nilsson","year":"1957","unstructured":"Nilsson IM, Blomb\u00e4ck B, Jorpes E, Blomb\u00e4ck M, Johansson SA (1957) Von Willebrand's disease and its correction with human plasma fraction I-O. Acta Med Scand 159: 179\u2013188","journal-title":"Acta Med Scand"},{"key":"BF01836069_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.0954-6820.1959.tb00189.x","volume":"164","author":"IM Nilsson","year":"1959","unstructured":"Nilsson IM, Blomb\u00e4ck M, Blomb\u00e4ck B (1959) Von Willebrand's disease in Sweden. Its pathogenesis and treatment. Acta Med Scand 164: 263\u2013278","journal-title":"Acta Med Scand"},{"key":"BF01836069_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0038-1654776","volume":"10","author":"IM Nilsson","year":"1963","unstructured":"Nilsson IM, Magnusson S, Borchgrevink C (1963) The Duke and Ivy methods for determination of the bleeding time. Thromb Diathes Haemorrh 10: 223\u2013234","journal-title":"Thromb Diathes Haemorrh"},{"key":"BF01836069_CR28","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1055\/s-0038-1657018","volume":"42","author":"IM Nilsson","year":"1979","unstructured":"Nilsson IM, Kirkwood TBL, Barrowcliffe TW (1979) In vivo recovery of factor VIII: a comparison of one-stage and twostage assay methods. Thromb Haemost 42: 1230\u20131239","journal-title":"Thromb Haemost"},{"key":"BF01836069_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0954-6820.1982.tb01909.x","volume":"211","author":"IM Nilsson","year":"1982","unstructured":"Nilsson IM, Vilhardt H, Holmberg L, \u00c5stedt B (1982) Association between factor VIII-related antigen and plasminogen activator. Acta Med Scand 211: 105\u2013112","journal-title":"Acta Med Scand"},{"issue":"Suppl 41","key":"BF01836069_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0609.1984.tb02776.x","volume":"33","author":"IM Nilsson","year":"1984","unstructured":"Nilsson IM, Borge L, Gunnarsson M, Kristoffersson AC (1984) Factor VIII-related activities in concentrates. Scand J Haematol 33 [Suppl 41]: 157\u2013172","journal-title":"Scand J Haematol"},{"key":"BF01836069_CR31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2141.1990.tb02654.x","volume":"75","author":"KJ Pasi","year":"1990","unstructured":"Pasi KJ, Williams MD, Enayat MS, Hili FGH (1990) Clinical and laboratory evaluation of the treatment of von Willebrand's disease patients with heat-treated factor VIII concentrate (BPL 8Y). Br J Haematol 75: 228\u2013233","journal-title":"Br J Haematol"},{"key":"BF01836069_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V30.3.375.375","volume":"30","author":"HA Perkins","year":"1967","unstructured":"Perkins HA (1967) Correction of the hemostatic defect in von Willebrand's disease. Blood 30: 375\u2013380","journal-title":"Blood"},{"key":"BF01836069_CR33","first-page":"497","volume-title":"Hemophilia and von Willebrand's dis-ease in the 1990s","author":"F Rodhegiero","year":"1991","unstructured":"Rodhegiero F, Gill JC (1991) Guidelines for the treatment of von Willebrand's disease with plasma derivatives. In: Lusher JM, Kessler CM (eds) Hemophilia and von Willebrand's dis-ease in the 1990s. Elsevier Science Publishers, Amsterdam, pp 497\u2013503"},{"key":"BF01836069_CR34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","volume":"57","author":"ZM Ruggeri","year":"1981","unstructured":"Ruggeri ZM, Zimmerman TS (1981) The complex multimeric composition of factor VIII\/von Willebrand factor. Blood 57: 1140\u20131143","journal-title":"Blood"},{"key":"BF01836069_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.1976.tb03533.x","volume":"33","author":"ZM Ruggeri","year":"1976","unstructured":"Ruggeri ZM, Mannucci PM, Jeffcoate SL, Ingram GIC (1976) Immunoradiometric assay of factor VIII-related antigen, with observations in 32 patients with von Willebrand's disease. Br J Haematol 33: 221\u2013232","journal-title":"Br J Haematol"},{"key":"BF01836069_CR36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/279636a0","volume":"279","author":"KS Sakariassen","year":"1979","unstructured":"Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279: 636\u2013638","journal-title":"Nature"},{"key":"BF01836069_CR37","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM198704093161505","volume":"316","author":"K Schimpf","year":"1987","unstructured":"Schimpf K, Mannucci PM, Kreutz W, et al. (1987) Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with haemophilia and no previous transfusions. N Engl J Med 316: 918\u2013922","journal-title":"N Engl J Med"},{"key":"BF01836069_CR38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V63.1.128.128","volume":"63","author":"JJ Sixma","year":"1984","unstructured":"Sixma JJ, Sakariassen KS, Beese-Visser NH, Ottenhof-Rovers M, Bolhuis PA (1984) Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Blood 63: 128\u2013139","journal-title":"Blood"},{"key":"BF01836069_CR39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1982.tb03888.x","volume":"52","author":"EGD Tuddenham","year":"1982","unstructured":"Tuddenham EGD, Lane RS, Rotblat F, et al. (1982) Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol 52: 259\u2013267","journal-title":"Br J Haematol"},{"key":"BF01836069_CR40","first-page":"7","volume":"67","author":"EA Willebrand von","year":"1926","unstructured":"Willebrand EA von (1926) Heredit\u00e4r pseudohemofili. Finska L\u00e4kars\u00e4llskapets Handlingar 67: 7\u201312","journal-title":"Finska L\u00e4kars\u00e4llskapets Handlingar"},{"key":"BF01836069_CR41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0049-3848(78)90268-2","volume":"12","author":"M Zuzel","year":"1978","unstructured":"Zuzel M, Nilsson IM, \u00c5berg M (1978) A method for measuring plasma ristocetin cofactor activity. Thromb Res 12: 745\u2013754","journal-title":"Thromb Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01836069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01836069\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01836069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T11:04:47Z","timestamp":1706353487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01836069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["BF01836069"],"URL":"https:\/\/doi.org\/10.1007\/bf01836069","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]}}}